Time to target evaluation criteria of targeted therapies
Nucl Med Commun
.
2009 Jul;30(7):487-9.
doi: 10.1097/MNM.0b013e3283294d32.
Authors
Carla M L van Herpen
,
Winette T A van der Graaf
,
Wim J G Oyen
PMID:
19512845
DOI:
10.1097/MNM.0b013e3283294d32
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use
Diagnostic Imaging
Humans
Neoplasms / diagnosis
Neoplasms / drug therapy
Neoplasms / therapy*
Treatment Outcome
Substances
Antineoplastic Agents